SensiGen

Shawn M. Marcell serves as President and Chief Executive Officer of SensiGen. Prior to joining SensiGen he was Senior Vice President of Commercialization at the Science Center in Philadelphia. There, he was responsible for commercialization of the 45,000 square foot incubator housing 36 companies, for venture funding of companies from SC Capital I, LP, and for marketing and communications. He also acted as CEO of the Science Center's lead portfolio company, Neuro Diagnostic Devices, Inc., which he formed and for which he raised the first rounds of financing.

Prior to joining the Science Center, he was business founder and CEO of Linguagen Corp. (now Redpoint Bio), a biotechnology company involved in the science of taste. There he raised over $15.0 million in venture financing, recruited a top flight management team and formed the development and commercial strategy of the company.

From 1994-2000 he was founder and CEO of Prima Facie, Inc. a digital imaging company with products aimed at the mobile security market. Following the sale of Prima Facie in 2000, Shawn accepted an appointment as adjunct Faculty at the University of Pennsylvania's Wharton School where he taught Business Plan Creation and Venture Initiation in the Management Department.

From 1990 -1994 Shawn was Global Head of Sales, Marketing and Business Development at Centocor, Inc., Diagnostics Division where he was responsible for businesses in the U.S., Europe and Japan. From 1983 - 1990 he held sales and marketing positions of increasing responsibility with Abbott Laboratories, Diagnostics Division.

Shawn is a frequent Lecturer at the Wharton School and a Fellow at the University of Pennsylvania's Weiss Tech House. He was twice named Ernst & Young Entrepreneur of the Year Finalist in the Philadelphia Region and has received the Frost & Sullivan Technology Company of the Year Award. Shawn's Companies have been highlighted on CNN, the BBC, in the Wall Street Journal, the New York Times, Newsweek, the Economist, and Money Magazine. He holds a BA in economics from George Washington University.

George G. Smith III is Senior Vice President, Corporate Development. Mr. Smith came to SensiGen after more 23 years in management consulting in the global Life Sciences Industry, most recently as partner in charge of the Life Sciences strategy consulting division of Accenture. Over his career, Mr. Smith has led numerous engagements in business strategy consulting, merger integration, operational improvement, R & D strategy, portfolio management, market and brand strategies, and shareholder value improvement for major life sciences and health care companies around the world. His clients have included more than a dozen of the world’s largest pharmaceutical firms, as well as a number of biotechnology firms, drug wholesalers, pharmacy benefit management companies, information and data services companies, generics manufacturers, and specialty chemicals producers. Mr. Smith graduated from the University of Pennsylvania with a Bachelor of Science degree in Mechanical Engineering and Physics. He also holds an MBA in Operations Research and Finance from the Wharton School of the University of Pennsylvania.

Jay Stoerker, PhD is Vice President of Product Development. Dr. Stoerker has over 20 years of biotechnology and academic experience from discovery through product launch with a primary technical expertise in molecular biology, genetics and mass spectrometry. Most recently, Dr. Stoerker served as Director of Technology Development for Matritech, Inc. where he led the technology development team that took markers from discovery analyte to clinical trials. Over his career, Dr. Stoerker has started and directed molecular diagnostics labs, has developed numerous nucleic acid diagnostic products, has been awarded patents for molecular diagnosis of tissue clonality, high risk pregnancy and methods of solid phase DNA mutation detection.

Dr. Stoerker began his career in diagnostics at Carolinas Medical Center in Charlotte North Carolina where he served as Director of Molecular Biology. While at Carolinas Medical Center, he provided molecular diagnostic services for HPV and cystic fibrosis testing through the Department of Obstetrics and Gynecology. Dr. Stoerker then took a product development position with Avitech Diagnostics and then went to Genzyme Genetics as Director of Technology Development for the DNA Diagnostics Lab in Framingham, MA. After his work at Genzyme, Dr. Stoerker joined Richert Research group at Tufts University for a one year fellowship in mass spectrometry of nucleic acids and then went to Bruker Daltonics as Senior Applications Scientist for Genomics and was promoted to Project Manager of Clinical Proteomics.

Dr. Stoerker holds a BS in microbiology from the University of Minnesota; an MS in applied microbiology; and a PhD in Medical Microbiology and Immunology from The Ohio State University. He was a post-doctoral fellow at the Institute for Molecular Virology, Erlangen, Germany.